Monaghan Medical yesterday touted data from a 6-month retrospective study showing that its Aerobika device reduced drug use for treatment of chronic obstructive pulmonary device.
The Syracuse, N.Y.-based company says its oscillating positive expiratory pressure therapy device is designed to expand the airways, help expel mucus to the upper airways and aid in drug deposition.
Get the full story at our sister site, Drug Delivery Business News.
The post Monaghan Medical touts Aerobika study appeared first on MassDevice.
from MassDevice http://ift.tt/2fdZHTh
Cap comentari:
Publica un comentari a l'entrada